$312 Million is the total value of ARMISTICE CAPITAL, LLC's 43 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 80.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | SPDR S&P 500 ETF TRput | $51,912,000 | +37.7% | 240,000 | +33.3% | 16.66% | +16.0% | |
| ATRS | Sell | ANTARES PHARMA INC | $20,664,000 | +27.5% | 12,300,000 | -20.3% | 6.63% | +7.5% |
| HAIN | Buy | HAIN CELESTIAL GROUP INC | $12,382,000 | +63.7% | 348,000 | +128.9% | 3.97% | +38.0% |
| ACOR | Buy | ACORDA THERAPEUTICS INC | $11,442,000 | +93.4% | 548,000 | +136.2% | 3.67% | +63.0% |
| ARLZ | Sell | ARALEZ PHARMACEUTICALS INC | $10,185,000 | +15.9% | 2,100,000 | -21.2% | 3.27% | -2.4% |
| RXDX | Sell | IGNYTA INC | $9,209,000 | +9.2% | 1,464,000 | -5.9% | 2.96% | -8.0% |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $9,171,000 | – | 268,000 | +100.0% | 2.94% | – |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $9,152,000 | +2.2% | 550,000 | -31.2% | 2.94% | -13.8% |
| PAY | New | VERIFONE SYS INC | $8,877,000 | – | 564,000 | +100.0% | 2.85% | – |
| Buy | VALEANT PHARMACEUTICALS INTLcall | $8,838,000 | +82.8% | 360,000 | +50.0% | 2.84% | +54.1% | |
| PDLI | New | PDL BIOPHARMA INC | $8,817,000 | – | 2,632,000 | +100.0% | 2.83% | – |
| LVS | Sell | LAS VEGAS SANDS CORP | $8,171,000 | +14.6% | 142,000 | -13.4% | 2.62% | -3.4% |
| FRPT | Buy | FRESHPET INC | $7,993,000 | +14.2% | 924,000 | +23.2% | 2.56% | -3.7% |
| NOMD | Sell | NOMAD HLDGS LTD | $7,565,000 | +18.5% | 640,000 | -20.0% | 2.43% | -0.1% |
| FLML | Buy | FLAMEL TECHNOLOGIES SAsponsored adr | $7,440,000 | +99.0% | 600,000 | +72.4% | 2.39% | +67.7% |
| DECK | Buy | DECKERS OUTDOOR CORP | $7,146,000 | +24.2% | 120,000 | +20.0% | 2.29% | +4.7% |
| SEAS | New | SEAWORLD ENTMT INC | $7,117,000 | – | 528,000 | +100.0% | 2.28% | – |
| KATE | Buy | KATE SPADE & CO | $6,852,000 | +28.9% | 400,000 | +55.0% | 2.20% | +8.6% |
| SGYPQ | Sell | SYNERGY PHARMACEUTICALS DEL | $6,832,000 | +35.2% | 1,240,000 | -6.8% | 2.19% | +13.9% |
| THC | Buy | TENET HEALTHCARE CORP | $5,982,000 | -5.1% | 264,000 | +15.8% | 1.92% | -20.0% |
| WFM | New | WHOLE FOODS MKT INC | $5,670,000 | – | 200,000 | +100.0% | 1.82% | – |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $5,641,000 | +6.6% | 212,000 | -11.7% | 1.81% | -10.2% |
| BWLD | Sell | BUFFALO WILD WINGS INC | $5,630,000 | -27.6% | 40,000 | -28.6% | 1.81% | -39.0% |
| MNRO | New | MONRO MUFFLER BRAKE INC | $5,261,000 | – | 86,000 | +100.0% | 1.69% | – |
| New | BEST BUY INC | $5,192,000 | – | 136,000 | +100.0% | 1.67% | – | |
| PERNIX THERAPEUTICS HLDGS INdebt 4.250% 4/0 | $4,834,000 | 0.0% | 22,760,000 | 0.0% | 1.55% | -15.7% | ||
| ABUS | Buy | ARBUTUS BIOPHARMA CORP | $4,816,000 | +239.2% | 1,400,000 | +243.1% | 1.54% | +185.6% |
| FLO | New | FLOWERS FOODS INC | $4,778,000 | – | 316,000 | +100.0% | 1.53% | – |
| AAP | New | ADVANCE AUTO PARTS INC | $4,474,000 | – | 30,000 | +100.0% | 1.44% | – |
| TGT | New | TARGET CORP | $4,396,000 | – | 64,000 | +100.0% | 1.41% | – |
| TTWO | Sell | TAKE-TWO INTERACTIVE SOFTWAR | $4,147,000 | -8.9% | 92,000 | -23.3% | 1.33% | -23.2% |
| AEGR | Buy | AEGERION PHARMACEUTICALS INC | $3,837,000 | +221.9% | 1,292,000 | +61.5% | 1.23% | +171.1% |
| FIT | New | FITBIT INCcl a | $3,710,000 | – | 250,000 | +100.0% | 1.19% | – |
| ALIM | New | ALIMERA SCIENCES INC | $3,683,000 | – | 2,472,000 | +100.0% | 1.18% | – |
| REPH | New | RECRO PHARMA INC | $3,536,000 | – | 400,000 | +100.0% | 1.14% | – |
| TLRDQ | Sell | TAILORED BRANDS INC | $3,360,000 | -61.4% | 214,000 | -68.9% | 1.08% | -67.5% |
| TTPH | Buy | TETRA TECHNOLOGIES INC DEL | $2,543,000 | +22.7% | 664,000 | +37.7% | 0.82% | +3.4% |
| TENX | Sell | TENAX THERAPEUTICS INC | $2,472,000 | -13.0% | 1,068,000 | -3.8% | 0.79% | -26.7% |
| BGFV | New | BIG 5 SPORTING GOODS CORP | $2,424,000 | – | 178,000 | +100.0% | 0.78% | – |
| QLTI | Buy | QLT INC | $2,298,000 | +47.7% | 1,115,455 | +1.8% | 0.74% | +24.5% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $1,674,000 | – | 132,000 | +100.0% | 0.54% | – |
| HSGX | New | HISTOGENICS CORP | $852,000 | – | 265,355 | +100.0% | 0.27% | – |
| ZSAN | New | ZOSANO PHARMA CORP | $662,000 | – | 838,000 | +100.0% | 0.21% | – |
| SNTA | Exit | SYNTA PHARMACEUTICALS CORP | $0 | – | -600,000 | -100.0% | -0.06% | – |
| Exit | OFFICE DEPOT INCcall | $0 | – | -139,900 | -100.0% | -0.18% | – | |
| MDGS | Exit | MEDIGUS LTDsponsored adr | $0 | – | -618,600 | -100.0% | -0.24% | – |
| LPCN | Exit | LIPOCINE INC NEW | $0 | – | -400,000 | -100.0% | -0.46% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -698,000 | -100.0% | -0.58% | – |
| LB | Exit | L BRANDS INC | $0 | – | -50,000 | -100.0% | -1.28% | – |
| RRR | Exit | RED ROCK RESORTS INCcl a | $0 | – | -158,000 | -100.0% | -1.32% | – |
| RH | Exit | RESTORATION HARDWARE HLDGS I | $0 | – | -128,000 | -100.0% | -1.40% | – |
| DMD | Exit | DEMAND MEDIA INC | $0 | – | -720,000 | -100.0% | -1.42% | – |
| HABT | Exit | HABIT RESTAURANTS INC | $0 | – | -236,000 | -100.0% | -1.47% | – |
| DFRG | Exit | DEL FRISCOS RESTAURANT GROUP | $0 | – | -272,000 | -100.0% | -1.48% | – |
| PZZA | Exit | PAPA JOHNS INTL INC | $0 | – | -58,000 | -100.0% | -1.50% | – |
| NILE | Exit | BLUE NILE INC | $0 | – | -148,000 | -100.0% | -1.54% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -96,000 | -100.0% | -1.58% | – |
| BCOR | Exit | BLUCORA INC | $0 | – | -500,000 | -100.0% | -1.97% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -138,000 | -100.0% | -2.20% | – |
| BDSI | Exit | BIODELIVERY SCIENCES | $0 | – | -2,652,000 | -100.0% | -2.38% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -400,000 | -100.0% | -2.51% | – |
| Exit | HAIN CELESTIAL GROUP INCcall | $0 | – | -150,000 | -100.0% | -2.84% | – | |
| TPX | Exit | TEMPUR SEALY INTL INC | $0 | – | -144,000 | -100.0% | -3.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.